Fidelity Investments’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Other funds holding WGS
CM
CC
AIM
VCM
ZDA
Fidelity Investments's WGS Position: Q1 2026 in Review
Fidelity Investments reduced its GeneDx Holdings (WGS) stake by 65% in Q1 2026, selling an estimated $49M and leaving 295,621 shares worth $19M. The position accounts for ﹤0.01% of the portfolio, ranked #1800.
Fidelity Investments first reported a position in WGS in Q3 2021 and has held it in 19 quarters since. The position peaked at $247M in Q1 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.
- Fidelity Investments held 295,621 shares of GeneDx Holdings worth $19M as of Q1 2026.
- Fidelity Investments sold 537,117 GeneDx Holdings shares in Q1 2026, an estimated $49M.
- GeneDx Holdings made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #1800 holding.
- Fidelity Investments first reported a position in GeneDx Holdings in Q3 2021 and has held it in 19 quarters since.
- Fidelity Investments's GeneDx Holdings position peaked at $247M in Q1 2025.
- 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.